
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Magnum Ice Cream Company has launched a mandatory open offer to acquire a 26% public stake in Kwality Walls for Rs 1,303 crore after its demerger from HUL.
SER Industries has approved a major ₹552.8 crore expansion by acquiring SNA Milk and DFSU Farmer Connect through a strategic share swap arrangement.
SER Industries Limited's board has approved amendments to its MOA/AOA, a new corporate office in Pune, and strategic acquisitions, signaling a major corporate overhaul.
Aditya Ispat Ltd. reports a significant 29.8% year-over-year drop in December 2025 sales, prompting the board to explore asset sales to manage operational losses and high finance costs.
Aditya Ispat Ltd. is exploring strategic options, including asset sales and capital infusion, to address significant operational losses and an eroded net worth reported in its latest financials.
Aditya Ispat Ltd. reports a significant 29.8% year-on-year decline in December 2025 sales, prompting the board to explore asset sales to address mounting operational losses.
Aditya Ispat reports a significant 29.8% year-on-year decline in December 2025 sales, prompting the board to consider asset sales and capital infusion to address mounting losses.
US President Donald Trump signed an executive order for a new 10% global tariff after the Supreme Court invalidated his previous use of emergency powers for trade duties.
Swiss parent Novartis AG announces the sale of its entire 70.68% stake in Novartis India for ₹1,446 crore, triggering a mandatory open offer and a 20% stock surge.
The Indian stock market faces a cautious session as traders weigh strong domestic industrial data against mixed global signals ahead of the Economic Survey 2026.
Gujarat-based Omnitech Engineering is set to launch its Rs 583 crore IPO from February 25 to 27, with a price band of Rs 216-227 per share.
Novartis India's shares surged nearly 20% after its Swiss parent, Novartis AG, announced the sale of its entire 70.68% stake to a ChrysCapital-led consortium for ₹1,446 crore.
Swiss drugmaker Novartis AG is selling its entire 70.68% stake in its listed Indian subsidiary to a ChrysCapital-led consortium for $159 million, marking its exit from India's public markets.
India's market regulator, SEBI, has issued a show-cause notice to Zee Entertainment and its leadership over allegations of significant fund diversion, reviving a multi-year investigation.
Swiss pharmaceutical giant Novartis AG announced the sale of its entire 70.68% stake in its listed Indian arm to a consortium led by ChrysCapital for ₹1,446 crore.
Swiss pharmaceutical giant Novartis AG has agreed to sell its entire 70.68% stake in its Indian-listed entity to a consortium led by private equity firm ChrysCapital.